Know what´s inside:

Bioactivation and Metabolism

In vitro assay support for the risk assessment of chemicals

Risk Assessment Assays

Next Generation Risk Assessment (NGRA) is an innovative approach to evaluating potential health risks of chemicals released into the environment and assessing their safety for human health. NGRA combines various methods, including in-silico, in-chemico, and in-vitro approaches, to obtain a comprehensive understanding of potential hazards.

Pharmacelsus, a leading company in pharmaceutical research and development, offers a wide range of established in-vitro assays in the field of bioactivation and metabolism. These assays enable the investigation of interactions between chemicals and biological systems to predict potential impacts on human health and the environment. Additionally, Pharmacelsus develops customized test series tailored to specific customer requirements.

A crucial component of the in-vitro assays are Pharmacelsus' powerful bioanalytics. The company possesses extensive experience in analyzing chemicals and their metabolites. Bioanalytics allows for accurate quantification of chemicals and their metabolic products, providing information on their metabolic pathways and potential toxicity. By combining in-vitro assays with bioanalytics, Pharmacelsus can deliver comprehensive data to support the risk assessment of chemicals.

Your contact at Pharmacelsus

MUDr. Maria Li
Director Business Development

Mobile: +49 173 889 4288

Business Development

Contact us!

To learn more about us and what we can do for you please contact our Director Business Development.

The experienced and highly committed Pharmacelsus team offers a variety of different services the following in Areas.

In vitro ADME


In vivo DMPK

In vitro & in vivo Toxicology

G(C)LP & non-GLP Bioanalytics

Biomarker Services

In vitro & in vivo Pharmacology

GBA Group Pharma

GBA Group Site

Mit dem Laden des Contents akzeptieren Sie Datenschutzbestimmungen von der GBA Group

Mehr erfahren

Pharmacelsus - Preclinical services

Pharmacelsus GmbH

Science Park 2
66123 Saarbrücken

Tel. +49 681 3946 - 7510
Fax +49 681 3946 - 7511

Member of the GBA Group since 2017.

© 2024 GBA Group

Volg ons

  • linkedIn GBA Group
  • xing
  • gba youtube
  • gba Instagram
ContactPrivacy Juridische informatie Algemene voorwaardenColofon
Telefoon Telefoon